| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |